Notify me when Ph.D. Noubar B. Afeyan files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| OMGAQ | OMEGA THERAPEUTICS, INC. | Common Stock, $0.001 par value per share | 53% | $1,461,279 | 29,225,579 | Noubar Afeyan | 29 Dec 2024 | ||
| OMGAQ | OMEGA THERAPEUTICS, INC. | Common Stock, $0.001 par value per share | 53% | $1,461,279 | -$96,158 | 29,225,579 | 0% | Noubar Afeyan | 03 Feb 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|